|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1300 North 17th Street |
Address2 | Suite 900 |
| City | Rosslyn |
State | VA |
Zip Code | 22209 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 27753-12
|
||||||||
|
6. House ID# 303820000
|
||||||||
| TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Peter Tolsdorf |
Date | 10/20/2022 11:03:49 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Meeting with House and Senate staff regarding appropriations for transformers via Defense Production Act authorities.
Meetings with House and Senate staff on CR/Omnibus issues that pertain to the electrical manufacturing industry.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Spencer |
Pederson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
NEMA staff met with house minority staff on Environment and Public Works to discuss electroindustry issues.
Meetings with House and Senate staff regarding TSCA implementation.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Sims |
|
|
|
Spencer |
Pederson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
Drafting a letter of support for H.R. 7981, Public and Federally Assisted Housing Fire Safety Act of 2022.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Sims |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MAN
16. Specific lobbying issues
Met with OMB, DOE, and EPA staff to ensure industry can meet the requirements in the Build America, Buy America Act.
Meeting and prep for meeting with the National Acquisition Center to discuss awards reporting, the new modification process, turnkey, and other topics.
Meetings with House and Senate staff on the CHIPS and Science Act of 2022 regarding electroindustry semiconductors and international standards.
Meetings with OMB, White House, and DOE staff on transformer manufacturing.
17. House(s) of Congress and Federal agencies Check if None
Veterans Affairs - Dept of (VA), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Environmental Protection Agency (EPA), Energy - Dept of, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Madeleine |
Bugel |
|
|
|
Laura |
Srebnik |
|
|
|
Spencer |
Pederson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Meetings with House staff on H.R. 6566 Freedom to Repair Act on maintaining medical device copyright protections.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Holly |
Grosholz |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Meetings with House staff and Senate Members and staff on H.R. 7677, the Food and Drug Amendments of 2022 and S. 4348, the Food and Drug Administration Safety and Landmark Advancements Act of 2022 to promote passage of user fees and issues related to medical device cybersecurity.
Meetings with House staff on H.R. 4006, the Fair Repair Act, to educate on medical device right to repair.
Strategy and outreach activities with regard to FDA request for comment on conducting remote regulatory assessments (Docket No. FDA-2022-D-0810: Conducting Remote Regulatory Assessments - Questions and Answers; Draft Guidance for Industry).
Strategy and outreach activities for the continued regulation of contrast and diagnostic radiopharmaceuticals as drugs in S. 4535, the Food and Drug Administration Simple Reauthorization Act, and H.R. 7667, Food and Drug Amendments of 2022.
Meetings with House and Senate staff on focused ultrasound policies to improve access in the VA Healthcare System.
Strategy and outreach activities with regard to FDA request for comment on conducting remote regulatory assessments (Docket No. FDA-2022-D-0810: Conducting Remote Regulatory Assessments - Questions and Answers; Draft Guidance for Industry).
Strategy and outreach activities for the continued regulation of contrast and diagnostic radiopharmaceuticals as drugs in S. 4535, the Food and Drug Administration Simple Reauthorization Act, and H.R. 7667, Food and Drug Amendments of 2022.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Holly |
Grosholz |
|
|
|
Susan |
Bunning |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
Meetings with House, Senate, White House, and DOE staff on supply chain issues facing the electroindustry.
Met with Senate minority staff on energy and natural resources impacting the electroindustry.
Drafting letter of support for H.R.7981 - Public and Federally Assisted Housing Fire Safety Act of 2022.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Energy - Dept of, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Spencer |
Pederson |
|
|
|
Todd |
Sims |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAR
16. Specific lobbying issues
Met with House and Senate, USTR, and DOC staff requesting the Section 301 tariff exclusions process be reopened and for relief from the Section 301 China and Section 232 steel and aluminum tariffs.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Commerce - Dept of (DOC), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Madeliene |
Bugel |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Met with USTR and DOC staff on barriers to trade and industry priorities for the Indo-Pacific Economic Framework and the US-EU Trade and Technology Council.
Meetings with House and Senate staff on S. 1260, USICA regarding trade provisions including 301 exemptions, GSP and MTBs.
17. House(s) of Congress and Federal agencies Check if None
U.S. Trade Representative (USTR), Commerce - Dept of (DOC), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Madeleine |
Bugel |
|
|
|
Spencer |
Pederson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Meetings with House and Senate members/staff including House Ways and Means, Energy and Commerce and Senate Finance Committee staff regarding the Facilitating Innovative Nuclear Diagnostics Act (S 2609/HR 4479).
Internal legislative strategy meetings; FIND Act Coalition legislative strategy meetings; physician and patient outreach; LTE campaign.
Strategy, advocacy, and outreach activities with regard to CMS request for comment on Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease (CAG-00431R) partial retirement of amyloid PET NCD.
Strategy, advocacy, and outreach activities with regard to CMS request for comment on AHRQ's proposal seeking comments on Topic Refinement Regarding Draft Analysis of Requirements for Coverage with Evidence Development.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Susan |
Bunning |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
BUD |
HCR |
NAT |
MAN |
HOM |
TRD |
|
|
|
ENG |
CSP |
ENV |
CPT |
TAR |
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |